Literature DB >> 31918554

Conservative management of staghorn stones.

M Alsawi1, T Amer2, M Mariappan3, S Nalagatla1, A Ramsay1, O Aboumarzouk2.   

Abstract

INTRODUCTION: Since the seminal works by Singh and Blandy in the 1970s, the management of staghorn stones has almost exclusively involved surgical intervention. In contrast, a more recent study found that conservative management was not as unsafe as previously believed. The present review sought to examine the available literature to understand the implications of a conservative strategy.
METHODS: A systematic search of the literature was carried out using MEDLINE®, Embase™ and the Cochrane Central Register of Controlled Trials. All papers looking at management of staghorn calculi were reviewed and studies with a conservative management arm were identified. Outcomes of interest were recurrent or severe urinary tract infections, progressive renal deterioration, dialysis requirements, morbidity and disease specific mortality. Owing to the lack of relevant data, a descriptive review was carried out.
RESULTS: Our literature search yielded 10 suitable studies involving a total of 304 patients with staghorn stones managed conservatively. Progressive renal deterioration occurred in 0-100% of cases (mean 27.5%) with a higher rate among bilateral staghorn sufferers (44% vs 9%). Dialysis was required in 9% of patients (20% bilateral, 6% unilateral). The mean rate of severe infection was 8.7% and recurrent urinary tract infections occurred in as high as 50% of cases (80% bilateral, 41% unilateral). Disease specific mortality ranged from 0% to 67% (mean 20.5%).
CONCLUSIONS: It appears that conservative management of staghorn calculi is not as unsafe as previously thought and selection of patients with unilateral asymptomatic stones with minimal infection should be considered.

Entities:  

Keywords:  Calculi; Conservative; Management; Staghorn; Stones

Mesh:

Year:  2020        PMID: 31918554      PMCID: PMC7099166          DOI: 10.1308/rcsann.2019.0176

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  17 in total

Review 1.  The contemporary management of renal and ureteric calculi.

Authors:  David J Galvin; Margaret S Pearle
Journal:  BJU Int       Date:  2006-12       Impact factor: 5.588

2.  The fate of the unoperated staghorn calculus.

Authors:  M Singh; R Chapman; G C Tresidder; J Blandy
Journal:  Br J Urol       Date:  1973-12

3.  Risk Factors for Postoperative Complications of Percutaneous Nephrolithotomy at a Tertiary Referral Center.

Authors:  Daniel Olvera-Posada; Thomas Tailly; Husain Alenezi; Philippe D Violette; Linda Nott; John D Denstedt; Hassan Razvi
Journal:  J Urol       Date:  2015-07-02       Impact factor: 7.450

Review 4.  Renal Replacement Therapy in Acute Kidney Injury: Controversies and Consensus.

Authors:  Michael Heung; Lenar Yessayan
Journal:  Crit Care Clin       Date:  2017-01-04       Impact factor: 3.598

Review 5.  An update on classification and management of urosepsis.

Authors:  Florian M E Wagenlehner; Zafer Tandogdu; Truls E Bjerklund Johansen
Journal:  Curr Opin Urol       Date:  2017-03       Impact factor: 2.309

6.  [Conservative treatment of staghorn and residual calculi (author's transl)].

Authors:  P Burchardt
Journal:  Urologe A       Date:  1982-01       Impact factor: 0.639

7.  Staghorn calculis: its clinical presentation, complications and management.

Authors:  A D Vargas; S D Bragin; R Mendez
Journal:  J Urol       Date:  1982-05       Impact factor: 7.450

Review 8.  Infections and urolithiasis: current clinical evidence in prophylaxis and antibiotic therapy.

Authors:  Giampaolo Zanetti; Stefano Paparella; Alberto Trinchieri; Domenico Prezioso; Francesco Rocco; Kurt G Naber
Journal:  Arch Ital Urol Androl       Date:  2008-03

9.  [Conservative treatment of staghorn calculi].

Authors:  J Flamm; F Forstik
Journal:  Z Urol Nephrol       Date:  1987-07

10.  Conservative management of staghorn calculi: a single-centre experience.

Authors:  Peter G Deutsch; Kesavapilla Subramonian
Journal:  BJU Int       Date:  2016-01-08       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.